vs

Side-by-side financial comparison of Organogenesis Holdings Inc. (ORGO) and UNITED FIRE GROUP INC (UFCS). Click either name above to swap in a different company.

UNITED FIRE GROUP INC is the larger business by last-quarter revenue ($365.8M vs $225.6M, roughly 1.6× Organogenesis Holdings Inc.). On growth, Organogenesis Holdings Inc. posted the faster year-over-year revenue change (78.1% vs 9.8%). Over the past eight quarters, Organogenesis Holdings Inc.'s revenue compounded faster (43.2% CAGR vs 11.2%).

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

The United Fruit Company was an American multinational corporation that traded in tropical fruit grown on Latin American plantations and sold in the United States and Europe. The company was formed in 1899 from the merger of the Boston Fruit Company with Minor C. Keith's banana-trading enterprises. It flourished in the early and mid-20th century, and it came to control vast territories and transportation networks in Central America, the Caribbean coast of Colombia, and the West Indies. Althou...

ORGO vs UFCS — Head-to-Head

Bigger by revenue
UFCS
UFCS
1.6× larger
UFCS
$365.8M
$225.6M
ORGO
Growing faster (revenue YoY)
ORGO
ORGO
+68.3% gap
ORGO
78.1%
9.8%
UFCS
Faster 2-yr revenue CAGR
ORGO
ORGO
Annualised
ORGO
43.2%
11.2%
UFCS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ORGO
ORGO
UFCS
UFCS
Revenue
$225.6M
$365.8M
Net Profit
$43.7M
Gross Margin
Operating Margin
28.1%
13.2%
Net Margin
19.4%
Revenue YoY
78.1%
9.8%
Net Profit YoY
469.5%
EPS (diluted)
$0.31
$1.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ORGO
ORGO
UFCS
UFCS
Q4 25
$225.6M
$365.8M
Q3 25
$150.9M
$354.0M
Q2 25
$101.0M
$335.5M
Q1 25
$86.7M
$331.1M
Q4 24
$126.7M
$333.2M
Q3 24
$115.2M
$323.0M
Q2 24
$130.2M
$301.2M
Q1 24
$110.0M
$296.0M
Net Profit
ORGO
ORGO
UFCS
UFCS
Q4 25
$43.7M
Q3 25
$21.6M
$39.2M
Q2 25
$-9.4M
$22.9M
Q1 25
$-18.8M
$17.7M
Q4 24
$7.7M
Q3 24
$12.3M
$19.7M
Q2 24
$-17.0M
$-2.7M
Q1 24
$-2.1M
$13.5M
Gross Margin
ORGO
ORGO
UFCS
UFCS
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Q1 24
73.9%
Operating Margin
ORGO
ORGO
UFCS
UFCS
Q4 25
28.1%
13.2%
Q3 25
13.7%
13.7%
Q2 25
-12.5%
8.7%
Q1 25
-30.9%
6.6%
Q4 24
8.1%
11.9%
Q3 24
5.4%
7.7%
Q2 24
-10.7%
-1.3%
Q1 24
-3.5%
5.5%
Net Margin
ORGO
ORGO
UFCS
UFCS
Q4 25
19.4%
Q3 25
14.3%
11.1%
Q2 25
-9.3%
6.8%
Q1 25
-21.7%
5.3%
Q4 24
6.1%
Q3 24
10.7%
6.1%
Q2 24
-13.1%
-0.9%
Q1 24
-1.9%
4.6%
EPS (diluted)
ORGO
ORGO
UFCS
UFCS
Q4 25
$0.31
$1.45
Q3 25
$0.11
$1.49
Q2 25
$-0.10
$0.87
Q1 25
$-0.17
$0.67
Q4 24
$0.05
$1.22
Q3 24
$0.09
$0.76
Q2 24
$-0.13
$-0.11
Q1 24
$-0.02
$0.52

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ORGO
ORGO
UFCS
UFCS
Cash + ST InvestmentsLiquidity on hand
$93.7M
$156.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$300.1M
$941.2M
Total Assets
$598.7M
$3.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ORGO
ORGO
UFCS
UFCS
Q4 25
$93.7M
$156.3M
Q3 25
$63.7M
$233.7M
Q2 25
$73.1M
$202.1M
Q1 25
$110.0M
$183.7M
Q4 24
$135.6M
$200.9M
Q3 24
$94.3M
$197.4M
Q2 24
$89.9M
$153.4M
Q1 24
$88.6M
$217.8M
Total Debt
ORGO
ORGO
UFCS
UFCS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Q1 24
$65.2M
Stockholders' Equity
ORGO
ORGO
UFCS
UFCS
Q4 25
$300.1M
$941.2M
Q3 25
$255.1M
$898.7M
Q2 25
$233.2M
$845.7M
Q1 25
$242.9M
$817.7M
Q4 24
$262.9M
$781.5M
Q3 24
$278.5M
$785.8M
Q2 24
$263.5M
$726.6M
Q1 24
$278.0M
$736.8M
Total Assets
ORGO
ORGO
UFCS
UFCS
Q4 25
$598.7M
$3.8B
Q3 25
$509.8M
$3.8B
Q2 25
$461.1M
$3.7B
Q1 25
$467.4M
$3.5B
Q4 24
$497.9M
$3.5B
Q3 24
$446.3M
$3.5B
Q2 24
$443.2M
$3.4B
Q1 24
$458.5M
$3.2B
Debt / Equity
ORGO
ORGO
UFCS
UFCS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×
Q1 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ORGO
ORGO
UFCS
UFCS
Operating Cash FlowLast quarter
$39.4M
$269.7M
Free Cash FlowOCF − Capex
$34.8M
FCF MarginFCF / Revenue
15.4%
Capex IntensityCapex / Revenue
2.1%
Cash ConversionOCF / Net Profit
0.90×
TTM Free Cash FlowTrailing 4 quarters
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ORGO
ORGO
UFCS
UFCS
Q4 25
$39.4M
$269.7M
Q3 25
$3.1M
$60.8M
Q2 25
$-32.9M
$53.4M
Q1 25
$-19.9M
$35.7M
Q4 24
$10.9M
$340.3M
Q3 24
$8.7M
$56.5M
Q2 24
$4.7M
$91.3M
Q1 24
$-10.2M
$36.2M
Free Cash Flow
ORGO
ORGO
UFCS
UFCS
Q4 25
$34.8M
Q3 25
$844.0K
Q2 25
$-36.5M
Q1 25
$-23.6M
Q4 24
$7.6M
Q3 24
$6.1M
Q2 24
$2.9M
Q1 24
$-12.4M
FCF Margin
ORGO
ORGO
UFCS
UFCS
Q4 25
15.4%
Q3 25
0.6%
Q2 25
-36.1%
Q1 25
-27.2%
Q4 24
6.0%
Q3 24
5.3%
Q2 24
2.2%
Q1 24
-11.3%
Capex Intensity
ORGO
ORGO
UFCS
UFCS
Q4 25
2.1%
Q3 25
1.5%
Q2 25
3.6%
Q1 25
4.2%
Q4 24
2.7%
Q3 24
2.2%
Q2 24
1.4%
Q1 24
2.0%
Cash Conversion
ORGO
ORGO
UFCS
UFCS
Q4 25
0.90×
Q3 25
0.14×
1.55×
Q2 25
2.33×
Q1 25
2.02×
Q4 24
1.43×
Q3 24
0.71×
2.86×
Q2 24
Q1 24
2.68×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons